COMP <GO>
CSW vs TMO // REVENUE GROWTH (YOY)
CSW Industrials Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CSW 6
— TMO 8
▲ REVENUE GROWTH (YOY) LEADER: CSW
LAST: $286.16 (-1.80%) • MKT CAP: $4.75B
revenue-growth
23.30%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CSW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.90% | 41.00% | +0.90 | CSW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.30% | 9.30% | -2.00 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.1x | 30.4x | -4.30 | CSW | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 2.40% | -0.27 | TMO | /fcf-yield <GO> |
| Operating Margin | 15.60% | 17.40% | -1.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.40% | 15.10% | -4.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 23.30% | 3.90% | +19.40 | CSW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.38% | 0.24% | +0.14 | CSW | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 4.50 | -0.77 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.6 | 59.1 | -17.56 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 0.94 | +0.15 | CSW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.6x | 36.3x | -0.70 | CSW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.75B | $262.22B | -$257.47B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CSW REV | TMO REV | CSW GROSS % | TMO GROSS % | CSW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.08B | $44.56B | 41.9% | 44.0% | $100.9M | $6.29B |
| FY 2024 | $878.3M | $42.88B | 44.8% | 44.0% | $128.8M | $7.27B |
| FY 2023 | $792.8M | $42.86B | 44.0% | 44.0% | $128.7M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSW // BETA 1.09
TMO // BETA 0.94